ANDA 84717, held by Cent Pharms. Prednisolone Acetate.
As of Nov 15, 2026, ANDA 84717 (Prednisolone Acetate), held by Cent Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Prednisolone Acetate25MG/ML · injectable;injection | Prednisolone Acetate | Discontinued |
| Prednisolone Acetate50MG/ML · injectable;injection | Prednisolone Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
